|
|
|
|
|
Detail |
| hsa-let-7a |
|
Causal |
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Let-7 expression defines two differentiation stages of cancer. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
RAS is regulated by the let-7 microRNA family. |
2005 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
let-7 regulates self renewal and tumorigenicity of breast cancer cells. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. |
2004 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
The let-7 microRNA represses cell proliferation pathways in human cells. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Detection of let-7a microRNA by real-time PCR in colorectal cancer: a single-centre experience from China. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Detection of let-7a microRNA by real-time PCR in gastric carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
MicroRNA signature predicts survival and relapse in lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
MicroRNA signatures in human ovarian cancer. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. |
2007 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer |
2009 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Let-7a elevates p21(WAF1) levels by targeting of NIRF and suppresses the growth of A549 lung cancer cells |
2009 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Integrin beta(3) expression is regulated by let-7a miRNA in malignant melanoma. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|